Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid (Q42688359)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 June 2012
edit
Language Label Description Also known as
English
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid
scientific article published on 18 June 2012

    Statements

    Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid (English)
    1 reference
    Lan Zhao
    1 reference
    Chien-Nien Chen
    1 reference
    Nabil Hajji
    1 reference
    Emanuele Cotroneo
    1 reference
    John Wharton
    1 reference
    Daren Wang
    1 reference
    Min Li
    1 reference
    Timothy A McKinsey
    1 reference
    Kurt R Stenmark
    1 reference
    Martin R Wilkins
    1 reference
    18 June 2012
    1 reference
    126
    1 reference
    455-467
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit